How to buy Evolent Health stock (EVH)

Evolent Health is a health information services business based in the US. Evolent Health shares (EVH) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $11.41 – an increase of 0.26% over the previous week. Evolent Health employs 4,700 staff and has a trailing 12-month revenue of around $2.5 billion.

Our top picks for where to buy Evolent Health stock

Buy Evolent Health stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Evolent Health stock price (NYSE: EVH)

Use our graph to track the performance of EVH stocks over time.

Evolent Health shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$11.41
52-week range	$10.53 - $35.00
50-day moving average more info button	$17.84
200-day moving average more info button	$24.39
Wall St. target price	$25.52
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.92

Is it a good time to buy Evolent Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Evolent Health price performance over time

Historical closes compared with the close of $11.18 from 2024-12-19

1 week (2024-12-13)	-1.76%
1 month (2024-11-21)	-3.54%
3 months (2024-09-20)	-63.98%
6 months (2024-06-21)	-50.31%

1 year (2023-12-21)	-64.70%
2 years (2022-12-21)	-58.38%
3 years (2021-12-21)	26.08
5 years (2019-12-20)	47.88%

Is Evolent Health stock undervalued or overvalued?

Valuing Evolent Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Evolent Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Evolent Health's EBITDA

Evolent Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $122.9 million.

The EBITDA is a measure of a Evolent Health's overall financial performance and is widely used to measure a its profitability.

Evolent Health financials

Revenue TTM	$2.5 billion
Gross profit TTM	$316.6 million
Return on assets TTM	0.73%
Return on equity TTM	-5.78%
Profit margin	-2.93%
Book value	$9.03
Market Capitalization more info button	$1.2 billion

TTM: trailing 12 months

Evolent Health share dividends

We're not expecting Evolent Health to pay a dividend over the next 12 months.

Evolent Health share price volatility

Over the last 12 months, Evolent Health's shares have ranged in value from as little as $10.53 up to $35. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Evolent Health's is 1.587. This would suggest that Evolent Health's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Evolent Health overview

Evolent Health, Inc. , through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Frequently asked questions

null
What percentage of Evolent Health is owned by insiders or institutions?
Currently 3.946% of Evolent Health shares are held by insiders and 115.782% by institutions. How many people work for Evolent Health?
Latest data suggests 4,700 work at Evolent Health. When does the fiscal year end for Evolent Health?
Evolent Health's fiscal year ends in December. Where is Evolent Health based?
Evolent Health's address is: 1812 N. Moore Street, Arlington, VA, United States, 22209 What is Evolent Health's ISIN number?
Evolent Health's international securities identification number is: US30050B1017 What is Evolent Health's CUSIP number?
Evolent Health's Committee on Uniform Securities Identification Procedures number is: 30050B101